Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies-Reference-Cited by-同舟云学术

Dissecting causes for improved survival among patients with acute myeloid leukemia in two different eras receiving identical regimens in sequential randomized studies

Published:2018-08-22 Issue:9 Volume:8 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Tiong Ing S.^ORCID, ,Reynolds John^ORCID,Bradstock Kenneth F.,Seymour John F.,Wei Andrew H.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-018-0121-4.pdf

Reference13 articles.

1. Derolf A. R., et al. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood 2009, 113, 3666–3672.

2. Pulte, D., Gondos, A. & Brenner, H. Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica 93, 594 (2008).

3. Bishop, J. F. et al. Etoposide in acute nonlymphocytic leukemia. Australian Leukemia Study Group. Blood 75, 27–32 (1990).

4. Bishop, J. F. et al. A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood 87, 1710–1717 (1996).

5. Bradstock, K. F. et al. A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine. Blood 105, 481–488 (2005).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia;International Journal of Laboratory Hematology;2022-02-25

2. Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy;Annals of Hematology;2021-03-11

3. Infection at diagnosis—a unique challenge in acute myeloid leukemia treatment in developing world;Supportive Care in Cancer;2020-03-12

4. From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia;Cancers;2020-02-04

5. Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges;Blood Reviews;2019-07